Long-Term Liabilities: The sum of all non-current liabilities.
Propanc Biopharma Inc (PPCB) had Long-Term Liabilities of $0.09M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-54.07M |
|
-- |
|
-- |
|
$53.13M |
|
$-53.13M |
|
$-0.94M |
|
$-54.07M |
|
$-54.07M |
|
$-54.07M |
|
$-54.07M |
|
$-54.07M |
|
$-54.07M |
|
$-53.13M |
|
$-53.13M |
|
4.33M |
|
4.33M |
|
$-12.50 |
|
$-12.50 |
|
| Balance Sheet Financials | |
$9.74M |
|
-- |
|
$12.79M |
|
$22.53M |
|
$4.34M |
|
$0.09M |
|
|
Long-Term Liabilities |
$0.09M |
$4.44M |
|
$18.09M |
|
$18.09M |
|
$18.09M |
|
11.61M |
|
| Cash Flow Statement Financials | |
$-0.38M |
|
-- |
|
$0.48M |
|
$0.02M |
|
$0.05M |
|
$0.03M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.24 |
|
-- |
|
-- |
|
0.01 |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-298.84% |
|
-298.84% |
|
-240.01% |
|
-297.30% |
|
$1.56 |
|
$-0.09 |
|
$-0.09 |
|